Home » Topics » Briefs » Other news to note

Other news to note
RSS

Fujisawa to transfer rights to Astra products

Oct. 18, 1996

Epoch-VIMRx alliance

Oct. 18, 1996

ICN Chinese joint venture

Oct. 18, 1996

Pall and Gelman open discussions

Oct. 18, 1996

Middlesex Sciences changes name

Oct. 18, 1996

Yamanouchi awaits marketing approval for new contraceptive

Oct. 11, 1996

Aldose reductase inhibitor in phase III at Fujisawa

Oct. 11, 1996

Antidiabetic agents from Yamanouchi's clinical pipeline

Oct. 11, 1996

Yamanouchi reports on GI drugs in development

Oct. 11, 1996

Gastrointestinal drugs in the pipeline at Fujisawa

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.